Greaney AJ, Starr TN, Barnes CO, Weisblum Y, Schmidt F, Caskey M, Gaebler C, Cho A, Agudelo M, Finkin S et al..  2021.  Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.. Nat Commun. 12(1):4196.

Bu W, M Joyce G, Nguyen H, Banh DV, Aguilar F, Tariq Z, Yap MLan, Tsujimura Y, Gillespie RA, Tsybovsky Y et al..  2019.  Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells.. Immunity. 50(5):1305-1316.e6.

Robbiani DF, Bozzacco L, Keeffe JR, Khouri R, Olsen PC, Gazumyan A, Schaefer-Babajew D, Avila-Rios S, Nogueira L, Patel R et al..  2017.  Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.. Cell. 169(4):597-609.e11.

Tzeng SY, Guarecuco R, McHugh KJ, Rose S, Rosenberg EM, Zeng Y, Langer R, Jaklenec A.  2016.  Thermostabilization of inactivated polio vaccine in PLGA-based microspheres for pulsatile release.. J Control Release. 233:101-13.

Tian T, Dubin K, Jin Q, Qureshi A, King SL, Liu L, Jiang X, Murphy GF, Kupper TS, Fuhlbrigge RC.  2012.  Disruption of TNF-α/TNFR1 function in resident skin cells impairs host immune response against cutaneous vaccinia virus infection.. J Invest Dermatol. 132(5):1425-34.